FOXA1 |
Ishikawa (endometrial adenocarcinoma) |
1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers) |
Permissive
Robust
|
Homo sapiens |
ENCSR000BKW
|
MA0148.4
|
FOXA1 |
T47D (invasive ductal carcinoma) |
1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers) |
Permissive
Robust
|
Homo sapiens |
ENCSR000BKY
|
MA0148.4
|
FOXA1 |
A549 (lung carcinoma) |
1 h with 100 nM Dexamethasone (Myers) |
Permissive
Robust
|
Homo sapiens |
ENCSR000BPX
|
MA0148.4
|
FOXA1 |
A549 (lung carcinoma) |
1 h with 0.02% Ethanol (Myers) |
Permissive
Robust
|
Homo sapiens |
ENCSR000BRD
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE26831
...
|
MA0148.4
|
FOXA1 |
T47D (invasive ductal carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE26831
...
|
MA0148.4
|
FOXA1 |
VCaP (prostate carcinoma) |
regular medium |
Permissive
Robust
|
Homo sapiens |
GSE14092
...
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
regular medium |
Permissive
Robust
|
Homo sapiens |
GSE14092
...
|
MA0148.4
|
FOXA1 |
lung adenocarcinoma |
Nkx2-1 negative |
Permissive
Robust
|
Mus musculus |
GSE43252
...
|
MA0148.4
|
FOXA1 |
lung adenocarcinoma |
Nkx2-1 negative |
Permissive
Robust
|
Mus musculus |
GSE43252
...
|
MA0148.4
|
FOXA1 |
prostate |
castrated+vehicle |
Permissive
Robust
|
Mus musculus |
GSE47192
...
|
MA0148.4
|
FOXA1 |
kidney |
castrated+testosterone |
Permissive
|
Mus musculus |
GSE47192
...
|
MA0148.4
|
FOXA1 |
caput epididymis |
intact |
Permissive
|
Mus musculus |
GSE47192
...
|
MA0148.4
|
FOXA1 |
prostate |
castrated+testosterone |
Permissive
Robust
|
Mus musculus |
GSE47192
...
|
MA0148.4
|
FOXA1 |
CyT49-derived endodermal cells |
none |
Permissive
Robust
|
Homo sapiens |
GSE54471
...
|
MA0148.4
|
FOXA1 |
CyT49-derived endodermal cells |
none |
Permissive
Robust
|
Homo sapiens |
GSE54471
...
|
MA0148.4
|
FOXA1 |
CyT49-derived endodermal cells |
none |
Permissive
Robust
|
Homo sapiens |
GSE54471
...
|
MA0148.4
|
FOXA1 |
CyT49-derived endodermal cells |
none |
Permissive
Robust
|
Homo sapiens |
GSE54471
...
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
vehicle, control |
Permissive
Robust
|
Homo sapiens |
GSE43678
...
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
10 nm DHT |
Permissive
Robust
|
Homo sapiens |
GSE43678
...
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
shCtrl |
Permissive
Robust
|
Homo sapiens |
GSE73363
...
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
shTET1 |
Permissive
Robust
|
Homo sapiens |
GSE73363
...
|
MA0148.4
|
FOXA1 |
VCaP (prostate carcinoma) |
none |
Permissive
Robust
|
Homo sapiens |
GSE77770
...
|
MA0148.4
|
FOXA1 |
VCaP (prostate carcinoma) |
DHT 10 nM |
Permissive
Robust
|
Homo sapiens |
GSE77770
...
|
MA0148.4
|
FOXA1 |
MCF-7L (invasive ductal carcinoma) |
tamoxifen |
Permissive
Robust
|
Homo sapiens |
GSE75201
...
|
MA0148.4
|
FOXA1 |
MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) |
tamoxifen |
Permissive
Robust
|
Homo sapiens |
GSE75201
...
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
No treatment |
Permissive
Robust
|
Homo sapiens |
GSE81714
...
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
Nonspecific siRNA |
Permissive
Robust
|
Homo sapiens |
GSE81714
...
|
MA0148.4
|
FOXA1 |
F9 (embryonal carcinoma) |
treated 48 hrs with RA |
Permissive
Robust
|
Mus musculus |
GSE82314
...
|
MA0148.4
|
FOXA1 |
T47D (invasive ductal carcinoma) |
DMSO |
Permissive
Robust
|
Homo sapiens |
GSE84593
...
|
MA0148.4
|
FOXA1 |
T47D (invasive ductal carcinoma) |
BYL719 |
Permissive
Robust
|
Homo sapiens |
GSE84593
...
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
control; 100 nM 17-beta-estradiol for 0h |
Permissive
Robust
|
Homo sapiens |
GSE85106
...
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
100 nM 17-beta-estradiol for 45 min |
Permissive
|
Homo sapiens |
GSE85106
...
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
100 nM 17-beta-estradiol for 3h |
Permissive
Robust
|
Homo sapiens |
GSE85106
...
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
ShMEN1 |
Permissive
Robust
|
Homo sapiens |
GSE94001
...
|
MA0148.4
|
FOXA1 |
VCaP (prostate carcinoma) |
siCtl |
Permissive
Robust
|
Homo sapiens |
GSE96652
...
|
MA0148.4
|
FOXA1 |
pancreatic ductal adenocarcinoma, liver metastasis |
Transduced with miR-E/shRen retrovirus |
Permissive
Robust
|
Mus musculus |
GSE99284
...
|
MA0148.4
|
FOXA1 |
pancreatic ductal adenocarcinoma, liver metastasis |
Transduced with miR-E/shFoxa1.2959 retrovirus |
Permissive
Robust
|
Mus musculus |
GSE99284
...
|
MA0148.4
|
FOXA1 |
cultured pancreatic ductal adenocarcinoma cells |
Transduced with MSCV/emp retrovirus |
Permissive
Robust
|
Mus musculus |
GSE99284
...
|
MA0148.4
|
FOXA1 |
cultured pancreatic ductal adenocarcinoma cells |
transduced with MSCV/FOXA1 retrovirus |
Permissive
Robust
|
Mus musculus |
GSE99284
...
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
Veh_90 |
Permissive
Robust
|
Homo sapiens |
GSE32222
...
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
Cocktail_90 |
Permissive
Robust
|
Homo sapiens |
GSE32222
...
|
MA0148.4
|
FOXA1 |
breast tumor |
Female |
Permissive
Robust
|
Homo sapiens |
GSE104399
...
|
MA0148.4
|
FOXA1 |
breast tumor |
Male |
Permissive
Robust
|
Homo sapiens |
GSE104399
...
|
MA0148.4
|
FOXA1 |
A1-2 (breast cancer cells) |
Treatment: 1hr EtOH |
Permissive
|
Homo sapiens |
GSE112491
...
|
MA0148.4
|
FOXA1 |
A1-2 (breast cancer cells) |
Treatment: 1hr Dex |
Permissive
|
Homo sapiens |
GSE112491
...
|
MA0148.4
|
FOXA1 |
A1A3(breast cancer cells) |
Treatment: 1hr EtOH, PBS 72 hr CellLine: A1A3 from T47D cell line |
Permissive
Robust
|
Homo sapiens |
GSE112491
...
|
MA0148.4
|
FOXA1 |
A1A3(breast cancer cells) |
Treatment: 1hr Dex, PBS 72 hr CellLine: A1A3 from T47D cell line |
Permissive
Robust
|
Homo sapiens |
GSE112491
...
|
MA0148.4
|
FOXA1 |
A1A3(breast cancer cells) |
Treatment: 1hr EtOH, Doxycycline 72 hr CellLine: A1A3 from T47D cell line Genotype: Brg1 knockdown |
Permissive
Robust
|
Homo sapiens |
GSE112491
...
|
MA0148.4
|
FOXA1 |
A1A3(breast cancer cells) |
Treatment: 1hr Dex, Doxycycline 72 hr CellLine: A1A3 from T47D cell line Genotype: Brg1 knockdown |
Permissive
Robust
|
Homo sapiens |
GSE112491
...
|
MA0148.4
|
FOXA1 |
MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) |
Treatment: 45 min 10^-7 4OHT |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA0148.4
|
FOXA1 |
MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) |
Treatment: 45 min 10^-7 4OHT |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA0148.4
|
FOXA1 |
MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) |
Treatment: 45 min 10^-7 4OHT |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA0148.4
|
FOXA1 |
MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) |
Treatment: 45 min ethanol |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA0148.4
|
FOXA1 |
MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) |
Treatment: 45 min ethanol |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA0148.4
|
FOXA1 |
MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) |
Treatment: 45 min ethanol |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA0148.4
|
FOXA1 |
MCF7 WS8 cells |
Treatment: 45 min 10^-7 4OHT |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA0148.4
|
FOXA1 |
MCF7 WS8 cells |
Treatment: 45 min 10^-7 4OHT |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA0148.4
|
FOXA1 |
MCF7 WS8 cells |
Treatment: 45 min 10^-7 4OHT |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA0148.4
|
FOXA1 |
MCF7 WS8 cells |
Treatment: 45 min 10^-8 E2 |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA0148.4
|
FOXA1 |
MCF7 WS8 cells |
Treatment: 45 min 10^-8 E2 |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA0148.4
|
FOXA1 |
MCF7 WS8 cells |
Treatment: 45 min 10^-8 E2 |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA0148.4
|
FOXA1 |
MCF7 WS8 cells |
Treatment: 45 min ethanol |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA0148.4
|
FOXA1 |
MCF7 WS8 cells |
Treatment: 45 min ethanol |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA0148.4
|
FOXA1 |
MCF7 WS8 cells |
Treatment: 45 min ethanol |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA0148.4
|
FOXA1 |
MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) |
Treatment: 45 min 10^-8 E2 |
Permissive
Robust
|
Homo sapiens |
GSE113092
...
|
MA0148.4
|
FOXA1 |
prostate tumor |
Patient: #1 |
Permissive
Robust
|
Homo sapiens |
GSE114385
...
|
MA0148.4
|
FOXA1 |
prostate tumor |
Patient: #2 |
Permissive
Robust
|
Homo sapiens |
GSE114385
...
|
MA0148.4
|
FOXA1 |
prostate tumor |
Patient: #3 |
Permissive
Robust
|
Homo sapiens |
GSE114385
...
|
MA0148.4
|
FOXA1 |
prostate tumor |
Patient: #4 |
Permissive
Robust
|
Homo sapiens |
GSE114385
...
|
MA0148.4
|
FOXA1 |
22RV1 (prostate carcinoma) |
Treatment: ethanol |
Permissive
Robust
|
Homo sapiens |
GSE80742
...
|
MA0148.4
|
FOXA1 |
22RV1 (prostate carcinoma) |
Treatment: R1881 |
Permissive
Robust
|
Homo sapiens |
GSE80742
...
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
Treatment: Cells were harvested in log phase growth Genotype: wildtype |
Permissive
Robust
|
Homo sapiens |
GSE85558
...
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
Treatment: Cells were harvested in log phase growth Genotype: HNF4G overexpression |
Permissive
Robust
|
Homo sapiens |
GSE85558
...
|
MA0148.4
|
FOXA1 |
22RV1 (prostate carcinoma) |
Treatment: Cells were harvested in log phase growth Genotype: wildtype |
Permissive
Robust
|
Homo sapiens |
GSE85558
...
|
MA0148.4
|
FOXA1 |
22RV1 (prostate carcinoma) |
Treatment: Cells were harvested in log phase growth Genotype: knockdown HNF4G |
Permissive
Robust
|
Homo sapiens |
GSE85558
...
|
MA0148.4
|
FOXA1 |
RT4 (Bladder carcinoma cells) |
Treatment: not applicable Stage:adult Tissue: transitional cell papilloma |
Permissive
Robust
|
Homo sapiens |
GSE86918
...
|
MA0148.4
|
FOXA1 |
RT4 (Bladder carcinoma cells) |
Treatment: not applicable Stage:adult Tissue: transitional cell papilloma |
Permissive
Robust
|
Homo sapiens |
GSE86918
...
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
Treatment: treated with 10nM R1881 for 4 hours |
Permissive
Robust
|
Homo sapiens |
GSE94682
...
|
MA0148.4
|
FOXA1 |
T47D (invasive ductal carcinoma) |
Passsage: <10 |
Permissive
Robust
|
Homo sapiens |
GSE99479
...
|
MA0148.4
|
FOXA1 |
T47D (invasive ductal carcinoma) |
Passsage: <10 |
Permissive
Robust
|
Homo sapiens |
GSE99479
...
|
MA0148.4
|
FOXA1 |
T47D (invasive ductal carcinoma) |
Passsage: <10 Genotype: wt/R330fs mutant with CRISPR |
Permissive
Robust
|
Homo sapiens |
GSE99479
...
|
MA0148.4
|
FOXA1 |
T47D (invasive ductal carcinoma) |
Passsage: <10 Genotype: wt/R330fs mutant with CRISPR |
Permissive
Robust
|
Homo sapiens |
GSE99479
...
|
MA0148.4
|
FOXA1 |
liver |
Strain: C57BL/6N Sex: male |
Permissive
Robust
|
Mus musculus |
GSE106379
...
|
MA0148.4
|
FOXA1 |
liver |
Strain: C57BL/6N Sex: male |
Permissive
Robust
|
Mus musculus |
GSE106379
...
|
MA0148.4
|
FOXA1 |
liver |
Strain: C57BL/6N Sex: male |
Permissive
Robust
|
Mus musculus |
GSE106379
...
|
MA0148.4
|
FOXA1 |
liver |
Strain: C3H/HeN Sex: male |
Permissive
Robust
|
Mus musculus |
GSE106379
...
|
MA0148.4
|
FOXA1 |
liver |
Strain: C3H/HeN Sex: male |
Permissive
Robust
|
Mus musculus |
GSE106379
...
|
MA0148.4
|
FOXA1 |
liver |
Strain: C3H/HeN Sex: male |
Permissive
Robust
|
Mus musculus |
GSE106379
...
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
siOCT1 |
Permissive
Robust
|
Homo sapiens |
GSE77770
...
|
MA0148.4
|
FOXA1 |
LNCaP95 |
Treatment: 10 nM ETOH for 4 hrs Genotype: shGFP transfection |
Permissive
Robust
|
Homo sapiens |
GSE106559
...
|
MA0148.4
|
FOXA1 |
LNCaP95 |
Treatment: 10 nM ETOH for 4 hrs Genotype: shARv7 transfection |
Permissive
Robust
|
Homo sapiens |
GSE106559
...
|
MA0148.4
|
FOXA1 |
LNCaP95 |
Treatment: 10 nM ETOH for 4 hrs Genotype: shARfl transfection |
Permissive
Robust
|
Homo sapiens |
GSE106559
...
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
Treatment: FA (control) |
Permissive
Robust
|
Homo sapiens |
GSE114737
...
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
Treatment: 2 mM DSG for 25 mins |
Permissive
Robust
|
Homo sapiens |
GSE114737
...
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: FA (control) |
Permissive
Robust
|
Homo sapiens |
GSE114737
...
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 2 mM DSG for 25 mins |
Permissive
Robust
|
Homo sapiens |
GSE114737
...
|
MA0148.4
|
FOXA1 |
primary prostate cancer |
Treatment: FA (control) |
Permissive
|
Homo sapiens |
GSE114737
...
|
MA0148.4
|
FOXA1 |
primary prostate cancer |
Treatment: 2 mM DSG for 25 mins |
Permissive
Robust
|
Homo sapiens |
GSE114737
...
|
MA0148.4
|
FOXA1 |
primary breast cancer |
Treatment: 2 mM DSG for 25 mins |
Permissive
Robust
|
Homo sapiens |
GSE114737
...
|
MA0148.4
|
FOXA1 |
primary prostate cancer |
Treatment: 2 mM DSG for 25 mins |
Permissive
Robust
|
Homo sapiens |
GSE114737
...
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: hormone-deprived cells treated with vehicle; |
Permissive
Robust
|
Homo sapiens |
GSE112969
...
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: hormone-deprived cells treated with 10 nM estrogen for 45 mins; |
Permissive
Robust
|
Homo sapiens |
GSE112969
...
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: hormone-deprived cells treated with vehicle; |
Permissive
Robust
|
Homo sapiens |
GSE112969
...
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: hormone-deprived cells treated with 10 nM estrogen for 45 mins; |
Permissive
Robust
|
Homo sapiens |
GSE112969
...
|
MA0148.4
|
FOXA1 |
ZR-75-1 (invasive ductal carcinoma) |
Treatment: hormone-deprived cells treated with 10 nM estrogen for 45 mins; |
Permissive
Robust
|
Homo sapiens |
GSE112969
...
|
MA0148.4
|
FOXA1 |
ZR-75-1 (invasive ductal carcinoma) |
Treatment: hormone-deprived cells treated with vehicle; |
Permissive
Robust
|
Homo sapiens |
GSE112969
...
|
MA0148.4
|
FOXA1 |
ZR-75-1 (invasive ductal carcinoma) |
Treatment: hormone-deprived cells treated with vehicle; |
Permissive
Robust
|
Homo sapiens |
GSE112969
...
|
MA0148.4
|
FOXA1 |
ZR-75-1 (invasive ductal carcinoma) |
Treatment: hormone-deprived cells treated with 10 nM estrogen for 45 mins; |
Permissive
Robust
|
Homo sapiens |
GSE112969
...
|
MA0148.4
|
FOXA1 |
22RV1 (prostate carcinoma) |
Treatment: DHT10 nM for 24 hrs; |
Permissive
Robust
|
Homo sapiens |
GSE123565
...
|
MA0148.4
|
FOXA1 |
22RV1 (prostate carcinoma) |
Treatment: ethanol (Vehicle) treatment for 24 hrs; |
Permissive
Robust
|
Homo sapiens |
GSE123565
...
|
MA0148.4
|
FOXA1 |
intestinal villus epithelial cells |
Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed +/+, Villin-CRE (wildtype); Strain: B6;129 mixed background; |
Permissive
Robust
|
Mus musculus |
GSE111024
...
|
MA0148.4
|
FOXA1 |
intestinal villus epithelial cells |
Day: 11; Treatment: Mice were injected with 1-2mg Tamoxifen for 5 consecutive days to activate tamoxifen-inducible Cre and recombine conditional alleles; Age: adult; Source: proximal 1/3 of intestine; Genotype: Eed F/F; Villin-CRE(Eed knockout); Strain: B6;129 mixed background; |
Permissive
Robust
|
Mus musculus |
GSE111024
...
|
MA0148.4
|
FOXA1 |
sperm |
Strain: CD1; |
Permissive
|
Mus musculus |
GSE116855
...
|
MA0148.4
|
FOXA1 |
NIH 3T3 (embryonic fibroblasts) |
Genotype: Overexpression of FOXA1; Treatment: treated overnight with 500 ng/ml of Doxycycline one day after seeding; |
Permissive
Robust
|
Mus musculus |
GSE119782
...
|
MA0148.4
|
FOXA1 |
T47D (invasive ductal carcinoma) |
E2_TAM |
Permissive
Robust
|
Homo sapiens |
ERP000380
|
MA0148.4
|
FOXA1 |
ZR-75-1 (invasive ductal carcinoma) |
E2_TAM |
Permissive
Robust
|
Homo sapiens |
ERP000380
|
MA0148.4
|
FOXA1 |
MDA-MB-453 (breast adenocarcinoma) |
DHT |
Permissive
Robust
|
Homo sapiens |
GSE45201
|
MA0148.4
|
FOXA1 |
HepG2 (hepatoblastoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BLE
|
MA0148.4
|
FOXA1 |
HepG2 (hepatoblastoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BMO
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR126YEB
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE26831
...
|
MA0148.4
|
FOXA1 |
T47D (invasive ductal carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE26831
...
|
MA0148.4
|
FOXA1 |
hepatocytes |
|
Permissive
Robust
|
Mus musculus |
GSE17067
...
|
MA0148.4
|
FOXA1 |
liver |
|
Permissive
Robust
|
Mus musculus |
GSE33666
...
|
MA0148.4
|
FOXA1 |
lung adenocarcinoma |
|
Permissive
Robust
|
Mus musculus |
GSE43252
...
|
MA0148.4
|
FOXA1 |
lung adenocarcinoma |
|
Permissive
Robust
|
Mus musculus |
GSE43252
...
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE72467
...
|
MA0148.4
|
FOXA1 |
HUES64 (embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE61475
...
|
MA0148.4
|
FOXA1 |
HUES64 (embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE61475
...
|
MA0148.4
|
FOXA1 |
HUES64 (embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE61475
...
|
MA0148.4
|
FOXA1 |
F9 (embryonal carcinoma) |
|
Permissive
Robust
|
Mus musculus |
GSE82314
...
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE94001
...
|
MA0148.4
|
FOXA1 |
22RV1 (prostate carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE96652
...
|
MA0148.4
|
FOXA1 |
pancreatic ductal adenocarcinoma |
|
Permissive
Robust
|
Mus musculus |
GSE99284
...
|
MA0148.4
|
FOXA1 |
pancreatic ductal adenocarcinoma |
|
Permissive
Robust
|
Mus musculus |
GSE99284
...
|
MA0148.4
|
FOXA1 |
pancreatic ductal adenocarcinoma |
|
Permissive
Robust
|
Mus musculus |
GSE99284
...
|
MA0148.4
|
FOXA1 |
pancreatic ductal adenocarcinoma, liver metastasis |
|
Permissive
Robust
|
Mus musculus |
GSE99284
...
|
MA0148.4
|
FOXA1 |
pancreatic ductal adenocarcinoma, peritoneum metastasis |
|
Permissive
Robust
|
Mus musculus |
GSE99284
...
|
MA0148.4
|
FOXA1 |
pancreatic ductal adenocarcinoma, peritoneum metastasis |
|
Permissive
Robust
|
Mus musculus |
GSE99284
...
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE25710
...
|
MA0148.4
|
FOXA1 |
ZR-75-1 (invasive ductal carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE25710
...
|
MA0148.4
|
FOXA1 |
T47D (invasive ductal carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE25710
...
|
MA0148.4
|
FOXA1 |
MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) |
|
Permissive
Robust
|
Homo sapiens |
GSE25710
...
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE25710
...
|
MA0148.4
|
FOXA1 |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR819LHG
|
MA0148.4
|
FOXA1 |
liver |
|
Permissive
Robust
|
Homo sapiens |
ENCSR324RCI
|
MA0148.4
|
FOXA1 |
HepG2 (hepatoblastoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR267DFA
|
MA0148.4
|
FOXA1 |
liver |
|
Permissive
Robust
|
Homo sapiens |
ENCSR735KEY
|
MA0148.4
|
FOXA1 |
HEK293T (embryonic kidney) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR094WHO
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ERP001226
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ERP001226
|
MA0148.4
|
FOXA1 |
MDA-MB-453 (breast adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ERP001226
|
MA0148.4
|
FOXA1 |
liver |
|
Permissive
Robust
|
Homo sapiens |
ERP002306
|
MA0148.4
|
FOXA1 |
|
|
Permissive
Robust
|
Homo sapiens |
ERP003828
|
MA0148.4
|
FOXA1 |
|
|
Permissive
Robust
|
Homo sapiens |
ERP003828
|
MA0148.4
|
FOXA1 |
|
|
Permissive
Robust
|
Homo sapiens |
ERP003828
|
MA0148.4
|
FOXA1 |
NCI-H3122 (lung adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE39998
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE52725
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE56288
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE64656
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE80808
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
E2_TAM |
Permissive
Robust
|
Homo sapiens |
ERP000380
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
TAMR_E2_TAM |
Permissive
Robust
|
Homo sapiens |
ERP000380
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE23852
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
ETOH |
Permissive
Robust
|
Homo sapiens |
GSE23852
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
DHT |
Permissive
Robust
|
Homo sapiens |
GSE28264
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
ETOH |
Permissive
Robust
|
Homo sapiens |
GSE28264
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
1F5 |
Permissive
Robust
|
Homo sapiens |
GSE30623
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
1F5_SIFOXA1 |
Permissive
Robust
|
Homo sapiens |
GSE30623
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
SHCTR_R1881 |
Permissive
Robust
|
Homo sapiens |
GSE37345
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
SHFOXA1_R1881 |
Permissive
Robust
|
Homo sapiens |
GSE37345
|
MA0148.4
|
FOXA1 |
HuH7 (hepatocellular carcinoma) |
ASYNC |
Permissive
Robust
|
Homo sapiens |
GSE39241
|
MA0148.4
|
FOXA1 |
HuH7 (hepatocellular carcinoma) |
MITO |
Permissive
Robust
|
Homo sapiens |
GSE39241
|
MA0148.4
|
FOXA1 |
LNCaP C4-2B (prostate carcinoma) |
DHT |
Permissive
Robust
|
Homo sapiens |
GSE40050
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
SICTR |
Permissive
Robust
|
Homo sapiens |
GSE40129
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
SIGATA |
Permissive
Robust
|
Homo sapiens |
GSE40129
|
MA0148.4
|
FOXA1 |
DU145 (prostate carcinoma) |
FOXA1_ARC562S |
Permissive
Robust
|
Homo sapiens |
GSE47987
|
MA0148.4
|
FOXA1 |
DU145 (prostate carcinoma) |
FOXA1_ARQ6540X |
Permissive
Robust
|
Homo sapiens |
GSE47987
|
MA0148.4
|
FOXA1 |
DU145 (prostate carcinoma) |
FOXA1_HIGH |
Permissive
Robust
|
Homo sapiens |
GSE47987
|
MA0148.4
|
FOXA1 |
VCaP (prostate carcinoma) |
ETOH |
Permissive
Robust
|
Homo sapiens |
GSE56086
|
MA0148.4
|
FOXA1 |
VCaP (prostate carcinoma) |
R1881 |
Permissive
Robust
|
Homo sapiens |
GSE56086
|
MA0148.4
|
FOXA1 |
VCaP (prostate carcinoma) |
SHCTR_R1881 |
Permissive
Robust
|
Homo sapiens |
GSE56086
|
MA0148.4
|
FOXA1 |
VCaP (prostate carcinoma) |
SHPIAS1_R1881 |
Permissive
Robust
|
Homo sapiens |
GSE56086
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
DHT24H |
Permissive
Robust
|
Homo sapiens |
GSE58428
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
ETOH24H |
Permissive
Robust
|
Homo sapiens |
GSE58428
|
MA0148.4
|
FOXA1 |
VCaP (prostate carcinoma) |
DHT24H |
Permissive
Robust
|
Homo sapiens |
GSE58428
|
MA0148.4
|
FOXA1 |
VCaP (prostate carcinoma) |
ETOH24H |
Permissive
Robust
|
Homo sapiens |
GSE58428
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE59530
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
E2_TNF |
Permissive
Robust
|
Homo sapiens |
GSE59530
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
TNF |
Permissive
Robust
|
Homo sapiens |
GSE59530
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE60270
|
MA0148.4
|
FOXA1 |
LNCaP-abl (Prostate carcinoma) |
SHCREB1 |
Permissive
Robust
|
Homo sapiens |
GSE63034
|
MA0148.4
|
FOXA1 |
LNCaP-abl (Prostate carcinoma) |
SHCTR |
Permissive
Robust
|
Homo sapiens |
GSE63034
|
MA0148.4
|
FOXA1 |
|
KOKLF5 |
Permissive
Robust
|
Homo sapiens |
GSE64557
|
MA0148.4
|
FOXA1 |
|
SHCTR |
Permissive
Robust
|
Homo sapiens |
GSE64557
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
ETOH |
Permissive
Robust
|
Homo sapiens |
GSE69043
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
PHFRPMIFCS |
Permissive
Robust
|
Homo sapiens |
GSE69043
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
R1881 |
Permissive
Robust
|
Homo sapiens |
GSE69043
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
SHGATA2_ETOH |
Permissive
Robust
|
Homo sapiens |
GSE69043
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
SHGATA2_R1881 |
Permissive
Robust
|
Homo sapiens |
GSE69043
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
DEX |
Permissive
Robust
|
Homo sapiens |
GSE72249
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE72249
|
MA0148.4
|
FOXA1 |
T47D (invasive ductal carcinoma) |
DEX |
Permissive
Robust
|
Homo sapiens |
GSE72249
|
MA0148.4
|
FOXA1 |
T47D (invasive ductal carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE72249
|
MA0148.4
|
FOXA1 |
ZR-75-1 (invasive ductal carcinoma) |
DEX |
Permissive
Robust
|
Homo sapiens |
GSE72249
|
MA0148.4
|
FOXA1 |
ZR-75-1 (invasive ductal carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE72249
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
DHT |
Permissive
Robust
|
Homo sapiens |
GSE83860
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
DHT_TNFA |
Permissive
Robust
|
Homo sapiens |
GSE83860
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
DMSO |
Permissive
Robust
|
Homo sapiens |
GSE83860
|
MA0148.4
|
FOXA1 |
LNCaP (prostate carcinoma) |
TNFA |
Permissive
Robust
|
Homo sapiens |
GSE83860
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ERP000380
|
MA0148.4
|
FOXA1 |
LNCaP C4-2B (prostate carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE40050
|
MA0148.4
|
FOXA1 |
DU145 (prostate carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE47987
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE59530
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE60270
|
MA0148.4
|
FOXA1 |
LNCaP-abl (Prostate carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE63034
|
MA0148.4
|
FOXA1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE72249
|
MA0148.4
|
FOXA1 |
T47D (invasive ductal carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE72249
|
MA0148.4
|
FOXA1 |
ZR-75-1 (invasive ductal carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE72249
|
MA0148.4
|